Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel 
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
- 29th Annual ROTH Conference on March 13, 2017 -
- 2016 Fourth Quarter and Full Year Financial Results Conference Call on March 16, 2017 -
VALENCIA, Calif., March 07, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) announced two upcoming events:
- Presenting at 29th Annual ROTH Conference on Monday, March 13, 2017 at 5:00 pm (PDT) at the Ritz Carlton in Dana Point, California.
To view and listen to the conference webcast, visit MannKind's website at http://www.mannkindcorp.com and click on the "29th Annual ROTH Conference" link in the Webcast section of News & Events.
- Release of 2016 fourth quarter and full year financial results on Thursday, March 16, 2017 and management to host a conference call to discuss financial results and other Company developments at 5:00 pm (EDT) on March 16, 2017.
To view and listen to the earning call webcast, visit MannKind's website at http://www.mannkindcorp.com and click on the "Q4 2016 MannKind Earnings Conference Call" link in the Webcast section of News & Events. To participate in the live call by telephone, please dial (888) 771-4371 or (847) 585-4405 and use the participant passcode: 44096370.
A telephone replay of the call will be accessible for approximately 14 days following completion of the call by dialing (888) 843-7419 or (630) 652-3042 and use the participant passcode: 4409 6370#. A replay will also be available on MannKind's website for 14 days.
As with past calls, the Company will take live questions from covering analysts. Stockholders who wish to submit questions in advance of the call should email them to [email protected].
About MannKind Corporation
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.
Company Contact: Rose Alinaya SVP Finance 661-775-5300 [email protected]
